Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G. Lip GY, et al. Among authors: boriani g. Europace. 2015 Dec;17(12):1777-86. doi: 10.1093/europace/euv269. Epub 2015 Aug 30. Europace. 2015. PMID: 26321406
Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
Gulizia M, Mangiameli S, Orazi S, Chiarandà G, Boriani G, Piccione G, DiGiovanni N, Colletti A, Puntrello C, Butera G, Vasco C, Vaccaro I, Scardace G, Grammatico A; PITAGORA (Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias) Investigators. Gulizia M, et al. Among authors: boriani g. Europace. 2006 Jul;8(7):465-73. doi: 10.1093/europace/eul055. Europace. 2006. PMID: 16798758 Clinical Trial.
Contribution of morphology discrimination algorithm for improving rhythm discrimination in slow and fast ventricular tachycardia zones in dual-chamber implantable cardioverter-defibrillators.
Boriani G, Occhetta E, Cesario S, Grossi S, Marconi M, Speca G, Silvestri P, Biffi M, Bortnik M, Martignani C, Branzi A. Boriani G, et al. Europace. 2008 Aug;10(8):918-25. doi: 10.1093/europace/eun146. Epub 2008 Jun 9. Europace. 2008. PMID: 18541620 Clinical Trial.
Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI).
Santini M, Russo M, Botto G, Lunati M, Proclemer A, Schmidt B, Erdogan A, Helmling E, Rauhe W, Desaga M, Santi E, Messier M, Boriani G. Santini M, et al. Among authors: boriani g. Europace. 2009 Apr;11(4):476-82. doi: 10.1093/europace/eun349. Epub 2009 Jan 9. Europace. 2009. PMID: 19136492 Free PMC article.
Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
Cowie MR, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M, de Roy L, Heidbuchel H, Verboven Y, Braunschweig F, Linde C, Boriani G. Cowie MR, et al. Among authors: boriani g. Europace. 2009 Jun;11(6):716-26. doi: 10.1093/europace/eup068. Epub 2009 Apr 9. Europace. 2009. PMID: 19359333
897 results